A Comperative Study on Health Sector in South Asia and Middle East Countries (Pharmacovigilance Insights) by Kolambil, Said Alavi & Jat, Rakesh Kumar
Kolambil et al                                                                                                 Journal of Drug Delivery & Therapeutics. 2019; 9(4-s):1096-1100 
ISSN: 2250-1177                                                                                  [1096]                                                                                 CODEN (USA): JDDTAO 
Available online on 25.08.2019 at http://jddtonline.info 
Journal of Drug Delivery and Therapeutics 
Open Access to Pharmaceutical and Medical Research 
© 2011-18, publisher and licensee JDDT, This is an Open Access article which permits unrestricted 
non-commercial use, provided the original work is properly cited 
Open  Access                                                                                                                                                     Research Article 
A Comperative Study on Health Sector in South Asia and Middle East 
Countries (Pharmacovigilance Insights) 
Said Alavi Kolambil*, Dr Rakesh Kumar Jat 
Institute of Pharmacy, Shri Jagdishprasad Jhabarmal Tibrewala Uinversity Vidya Nagari, Chudela Jhunjhunu, India 
 
ABSTRACT 
The market mesmerized innumerable count of medicine especially in south Asian countries as well in middle east, irrationaliti es on drug 
promotional activities, lack of proper monitoring in existing system, failure on to promote individual patient care through proper advices, In 
simple words, pharmacovigilance insights needs to be elaborated, because the activities related purely on drugs, and no one free from adverse 
effects. Even in the existing pharmacovigilance system were found under reporting on ADR amongst the health care providers, it needs to 
develop new dimensional view, and to create public awareness programs on this regards. The illustrated data collected 463 exp erts in health 
care field from Middle East and South Asian region, specially emphasized on introspective view of participants’ on reporting adverse drug 
reaction and indirectly asked general population views on this regards. It needs to address pharmacovigilance system have major role to play 
improve quality of life, It is concluded that on reporting adverse drug reaction most of the people hesitated in existing facilities due to 
complicacy in procedure, factors like time constraints, lack awareness about this programs, But almost welcomed if the patient going to report 
adverse drug reaction directly. Simplicity in procedure is the major concern. 
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INTRODUCTION 
The term coined by the WHO as science and activities 
related to the detection, assessment, understanding and 
prevention of adverse effects or any other drug related 
problems. Why the importance needs to be raised, when the 
drug molecule introduced in the market, rarely trial have 
been conducted thousands of people, excluded especially in 
geriatric as well as pediatric population, even completely 
avoided both in pregnant and lactating women, Scaffidi et al 
(2016) disclosed the facts based on this studies found 
meagerly pregnancy related research reported, and 
neglected therapeutic uses of medicines in pregnant ladies 
especially in emergency situation and even lack of clinical 
evidences, leads to complication in later practice 
(teratogenicity). But the drugs in clinical practices followed 
in masses at varied doses for longer time instead of fixed 
dose conducted just few weeks as in clinical trial system. 
Here noted facts that once drugs launched in the market, it 
take longer time to withdraw from the market due to 
adverse drug reaction,  
It needs special concern in geriatric population, increased 
medical needs as they grow older who were switched on 
poly pharmacy, prone to drug interaction and adverse drug 
reactions, together hindered patient’s adherence, finally 
periled quality of patient’s life. The term adverse drug 
reaction is in itself great virtue, WHO coined the terms as 
any response to a drug which is noxious, un intended and 
occurs as does used in man for prophylaxis and diagnosis or 
therapy of disease or modification of physiological function. 
Here definition itself excluded over accidental or intentional, 
under this purview eliminated the facts such as drug abuse, 
therapeutic failure and drug administration error. Bertram 
G. Katzung et al (2013) explained importance of Adverse 
drug reaction that occurs in susceptible patients due to 
intolerance, idiosyncrasy, or it may be immunologically 
mediated, most of them screened out in IND or in phase 1 to 
3 clinical trial, before launched in the market. Here all 
adverse drug reaction (it may be serious or life threatening, 
disabling, or reasonably drug related or unexpected) must 
be reported on concerned ministry of health. Recently FDA 
disclosed that adverse drug reaction is the one of the fourth 
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causes leading to death, which were found higher than 
pulmonary diseases, AIDS, accidents and automobile deaths.  
WHO enumerated majority of people still depends on 
traditional forms of medicines especially both in 
undeveloped and developing countries. But the situation 
maneuvered by cooperate lobbies especially in Asian 
countries.Bchav SS (2015) reviewed 318 articles on 
utilization studies on drugs, counted on irrational 
prescription, enlightened needs for monitoring system, 
remedial solution to counteract this problem still in 
confused facts. R Purushotham Naidu (2013) peer reviewed 
studies highlighted on current market flooded with drugs, 
which day to day increasing, here aggressive marketing 
technology partially encouraged mass consumption of drugs 
and producing environmental wastages.  Regulating 
authorities needs to take precautionary measures to curtail 
on disease mongering situation, and implement legislative 
policies. 
Lisha J,J (2012) studies conducted in tertiary care hospitals 
in UAE revealed that meagerly reporting ADR, the clinician 
were found willing to participate on ADR monitoring system, 
however pharmacovigilance insights were found still in 
infancy. Similar studies found by Subramaniyan (2016) 
conducted in India, highlighted “the importance of 
pharmacovigilance system” well known things on part of 
nurses and doctors, however studies revealed that 
practically they were found hesitated to report ADR on 
existing system. Mohamed N Al-Narifi (2015) gives 
prominence to report adverse drug reaction based on his 
study, generally physician welcomed to report ADR, but 
averted because of legal consequences and dissuaded due to 
attitude of concerned staff (pharmacist). The fruitfulness can 
achieved through by ensuring inter professional 
coordination between different professional groups working 
in health care field. Prashansa Agarwal(2014) highlighted 
importance of pharmacovigilance system in Drug discovery 
and development process, the subjects involved scrutinizing 
submission  reports on adverse drug events in new drug 
development process, and should establish independent 
drug safety monitoring boards, the concerning bodies 
responsible for onto  present summaries on serious adverse 
events, periodic monitoring on drugs used for chronic 
disease and disorders, and overall activities related to 
beneficial effects of drugs, weighed on risks involved on this 
subject matter. It gives comprehensive view on risk 
management plan (RMP), Fatima Suleman (2010), illustrated 
view on importance of pharmacovigilance system especially 
concerned responsibility of drug manufactures, drug 
regulating authorities, and in public health programs, clinical 
institutions, academic researchers, health care providers, as 
well in media, and on part of large consumers. Based on this 
study, author postulated lack of understanding what should 
do on reporting ADR and other minor things like time 
constraints, and heavy works loads on paper, it also 
advocated that pharmacist have major role to play on 
monitoring existing pharmacovigilance system. 
METHODOLGY  
As the studies focus on health care providers, professional 
commitment, attitudes towards practicing, people concerned 
expectations as well as contributing factors on ethical 
dilemma, and also dialectical peculiarities were noticed. The 
research based on direct personal contact and also online 
reply by the respondents. For the justification, it used 
specific research tools, “questionnaire and interview guide” 
to study survey, point out that in qualitative and quantitative 
in nature, in fact questionnaire at large and interview guide 
at lesser extent to gather exhaustively bigger information in 
all 463 samples (physician – 179, Dentist 43, pharmacist 66, 
nurses 45, Researcher 52, professors-66) considered on this 
part of studies. 
In the survey design, the most important facts to design 
standardized questionnaire, it free from personal bias, 
initially data collection done by observing on consumer’s 
attitude, concerned general perception whole community in 
health care system, the researcher spend time in Dubai 
(UAE), Sohar, Muscat (Oman), in which large amount of 
international migrant met from the region of south Asia and 
middle east, and in south India, it takes four years and takes 
maximum efforts to reach in a conclusion. Here author not 
only closely inspected on attitude, and perception of people 
related on health promoting activities but also behavior of 
shoppers, and health care providers and other intermediate 
agencies (representatives, consultant agencies), systematic 
approach done throughout this studies to carry out 
functioning on  this research studies which attributed in 
quantitative and in qualitative terms. 
Sample techniques 
For this study, simple stratified random sampling techniques 
as well as direct personal approach concerned through 
questionnaire, In this study researcher bottom out both 
primary and secondary data, the research survey limited 
only a few of the members distributed in wild geographic 
area. There are 463 respondents are chosen using random 
sample techniques, in which lottery method used for the 
selection of respondents. 
Here questionnaire designed closed one, here participants 
can mark any one of the option based on his/hers 
presumption, opinion on conventional practice of adverse 
drug reporting system, revealed introspective views and 
shared personal experiences based on his/hers clinical 
experiences, also dictated suggestive methods in 
counterpart on general population on reporting adverse 
drug reaction. 
Time Dimension 
The present studies were cross sectional one, as the nature 
of studies it have limitation on to conduct longitudinal 
research, repeated research articles relevant to topic 
published in different areas partially implicated failure on to 
implementation of health policy, without suggesting any 
remedial solution, data collection for this research studies 
carried over eleven months from expert members under this 
subject consideration in south Asia (India, Pakistan, 
Bangladesh and, Nepal) middle east countries (Egypt, turkey, 
Saudi, Oman, UAE, Iran, Iraq, Jordan). 
DATA ANALYSIS:  
Analysis classification of Data (Demographic Profiles) 
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Demographic data profile in this research data interpreted, 
in certain extent it have crucial role to play based on subject 
studies, the analysis of diagram represented a total of 463 
participant in which 296 participants were found male, and 
remaining 167 respondents were found female, the 
weightage given almost same for both sex (male/female)  
Analysis classification of Data (Profession) 
the subjects related on health care, almost all section of the 
societies who served in clinical field considered on this 
subjects, here priority given to the physician because of all 
role on this relevant field subjugated (accustomed in their 
clinical practice), by them.  Even these studies under 
consideration education of participants, which reflected on 
this studies many factors like quality of participants, 
behavior of respondents, research competencies, and 
innovative capabilities.  
The analysis of above data represented different stake 
holders in health care field like physician, dentist, 
professors, researcher, pharmacist, nurses. In which overall 
179 physician in the region of South Asia (138) and 
counterpart Middle East countries (41).Dentist being 
participated on this research studies a total of 43 from south 
Asian region (32), and one from Middle East found eleven 
participants.  
And a total 78 highly experienced medical professors 
worked in familiar institutes around the globe, from the 
south Asian region (62), and one counterpart from Middle 
East countries (16), and a total of 62 well expert researches 
practicing in clinical field, from South Asian countries (44), 
from Middle East countries (8), and pharmacist who were 
well known things based on his clinical exposure, A total of 
66 pharmacist participated on this studies from south Asian 
region (40) and one from Middle East (26), one of the major 
mediator in clinical field like 45 nurses participated on this 
studies from the region of south Asia (27), counterpart from 
Middle East countries (18). 
 
 
 
The above table illustrated on experience of health care 
providers in their clinical practices. Initially a total of 520 
participants responded on this research studies, through 
online survey conducted by using Google forms 
(admaero2017@gmail.com, admaero2000@gmail.com, 
admaero2018@gmail.com,) and on by offline service 
through by personal approach. However 57 participants 
rejected due to incomplete data, and on by below three years 
experiences found. Based on subjects considered importance 
of experience in clinical fields’ minimum of three years 
Finally selected a total of 463 participants to those whom 
experience between 3 to 6 years found (201+43.19%), 
between 7 to 10 years (93+20.08%), between to 11 to 14 
(59+12.74%), between 15 to 19(52+11.23%), between 20 
and above (58+12.52%) 
 
Analysis of classification of Data (HCP’s Introspective 
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The above picture show introspective view of health care 
professionals on reporting adverse drug reaction on their 
clinical findings such as don’t know how to report them 
(50+10.9%), ADR reporting is not mandatory (137+29.9%), 
lack of time (61+13.3%), nearly half of the participants 
commented through this statement “complicacy of 
procedure (210+45.9%)” primarily needs to be addressed, 
and five participants withdrawn to comment on this 
statement. 
Analysis of classification of Data (General view on ADR - 
Reporting), How is likely that you recommend to the 
patient, if he/she is going to report ADR directly? 
 
The above picture depicted on (if once the ADR reporting 
system encouraged and implemented for  the public)  how 
can maintain true validity, and general view of health care 
providers on relevant question, the statement made “It is not 
necessary ADR is already mentioned in the patient inform 
leaflet” marked (99+21.4%), and one second statement “they 
can report ADR because it prevents harms to others” 
(130+28.1%), and one third statement almost one third of 
the population assured “They can report ADR directly 
because of its difficulty to discuss with medical and allied 
healthcare professionals” (145+31.4%) and one fourth 
option “I benefit from reporting ADR because it contributes 
research and knowledge” opted meagerly 88 participants 
found valid percentage 19, out of 463 participants, one 
person  not made any comment on them. 
RESULTS 
The data shows significant difference whether health care 
professionals ideally placed, on to spot adverse drug 
reactions and to play an important role in the long term 
monitoring commonly prescribed drugs, final statement 
shows introspective view on adverse drug reaction 
monitoring system by the health care providers, the 
parameters selected based on literature reviews, Don’t know 
how to report them, ADR reporting is not mandatory, lack of 
time, and complicacy of procedures, here nearly half of the 
participants agreed on terms of complicacy in procedure, 
and one third of participants agreed in terms of ADR 
reporting is not mandatory, and one sixth participants 
agreed due to lack of time, remaining ten percentages of 
participants statement made don’t know how to report 
them.  
Here under consideration on spontaneous reporting system, 
illustrated in the next statement “How is likely that you 
recommend to the patient, if he/she is going to report ADR 
directly?” responses were made like It is not necessary ADR 
is already mentioned in the patient inform leaflet, They can 
report ADR because it prevents harm to others, They can 
report ADR directly because of its difficulty to discuss with 
medical and allied healthcare professionals, I benefit from 
reporting ADR because it contributes research and 
knowledge. Here more than one third of participants opined 
“they can report ADR directly because of difficulty to discuss 
with medical and allied health care providers” it may be due 
to previous statement made due to lack of time, or here 
patient were direct victim, he/she can gives  more accurate 
description, once they have suffered. Nearly one third of 
participants agreed on the second statement “patient can 
report ADR because it prevents harms to others” partially 
suggested, importance on encouraging ADR reporting 
system amongst the public. Nearly one fifth of the 
participants found dedicated personalities commented 
through this statement “I benefit from reporting ADR 
because it contributes research and knowledge.”  
DISCUSSION 
The subjects  under consideration on spontaneous reporting 
system,  the similar statement made by Mireille (2010), 
needs for encouragement  to report adverse drug reaction 
spontaneously, here statistical data monitored especially on 
long term used drugs, briefed on this statement “How is 
likely that you recommend to the patient, if he/she is going 
to report ADR directly?” responses were made like one “It is 
not necessary ADR is already mentioned in the patient 
inform leaflet, They can report ADR because it prevents 
harm to others, They can report ADR directly because of its 
difficulty to discuss with medical and allied healthcare 
professionals, I benefit from reporting ADR because it 
contributes research and knowledge”. Here more than one 
third of participants opined “they can report ADR directly 
because, it is difficult to discuss with medical and allied 
health care providers” it may be due to lack of time on part 
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of physician found, who were engaged in busy schedule. 
Here patient were direct victim, he/she can gives more 
accurate description, once they have suffered. Nearly one 
third of participants agreed on the second statement 
“patient can report ADR because it prevents harms to 
others” partially suggested, importance on encouraging ADR 
reporting system amongst the public. N Shiva Krishna 
(2016) opined pragmatic methods to report ADR reporting 
system in hospital system, however spontaneous reporting 
system have wide concern, usually health care providers 
hesitated due to uncertainty about drug causing ADR, here 
this  problem can solved by designing suitable software with 
help of statistical tool, it can verified on commonly 
encountered drug effects.  It needs to awareness programs 
amongst the people, it benefited whole community as one 
recommended by Mangala S (2013), Kishor B. Rathod 
(2015) have conducted studies in rural areas in India. The 
above view also supported by the Mohammed Alshaka 
(2010), Khan MA (2014),proposed integration of technology 
through interconnectivity regionally as well as one with 
internationally (like MADRAC- in Malaysia), The studies 
focused in developing countries suggested that institutional 
level reporting ADR system should be changed because of 
enthusiasm on stakeholders increased, it should promoted 
consumer awareness programs in general population.  
By these studies nearly one fifth of the participants found 
dedicated personalities commented through this statement 
“I benefit from reporting ADR because it contributes 
research and knowledge” Inez Rebeoro Vaz (2016) stated 
that out of 3865 articles reviewed in 29 different projects 
hinted that (from which 24 percentage ADR reported by the 
patient, three fourth reported by the health care 
professionals, here electronic media provides valuable 
information gives aggregated percentage on ADR. Christine 
M. Thorp (2008) in earlier publication inscribed role of 
health care professionals on to report adverse drug reaction 
especially commonly used one in long terms. As 
professionals, they should be able to advise patient and in 
needy cases refer to them on to other experts in health care 
field. 
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